Sethoxydim; Pesticide Tolerances, 39256-39261 [E8-15519]
Download as PDF
39256
Federal Register / Vol. 73, No. 132 / Wednesday, July 9, 2008 / Rules and Regulations
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of this final rule in the
Federal Register. This final rule is not
a ‘‘major rule’’ as defined by 5 U.S.C.
804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: June 24, 2008.
Debra Edwards,
Director, Office of Pesticide Programs.
Therefore, 40 CFR chapter I is
amended as follows:
I
PART 180—[AMENDED]
1. The authority citation for part 180
continues to read as follows:
I
Commodity
Potato, flakes ..................
Small fruit vine climbing
subgroup, except fuzzy
kiwifruit, subgroup 1307F ..............................
Strawberry ......................
Vegetable, cucurbit,
group 9 ........................
Vegetable, fruiting, group
8 ..................................
Vegetable, leafy, except
Brassica, group 4 ........
Vegetable, tuberous and
corm, subgroup 1C
2. Section 180.641 is added to read as
follows:
§ 180.641 Spirotetramat; tolerances for
residues.
(a) General. (1) Tolerances are
established for residues of the
insecticide spirotetramat (cis-3-(2,5dimethlyphenyl)-8-methoxy-2-oxo-1azaspiro [4.5] dec-3-en-4-yl-ethyl
carbonate) and its metabolites BYI
08330-enol (cis-3-(2,5-dimethylphenyl)4-hydroxy-8-methoxy-1-azaspiro 4.5
dec-3-en-2-one), BYI 08330-ketohydroxy
(cis-3-(2,5-dimethylphenyl)-3-hydroxy8-methoxy-1-azaspiro 4.5 decane-2,4dione), BYI08330-enol-Glc (cis-3-(2,5dimethylphenyl)-8-methoxy-2-oxo-1azaspiro 4.5 dec-3-en-4-yl beta-Dglucopyranoside), and BYI 08330-monohydroxy (cis-3-(2,5-dimethylphenyl)-4hydroxy-8-methoxy-1-azaspiro 4.5
decan-2-one), calculated as
spirotetramat equivalents, in or on the
following raw agricultural commodities:
dwashington3 on PRODPC61 with RULES
Commodity
Parts per million
15:16 Jul 08, 2008
0.60
Commodity
Parts per million
Cattle, fat ........................
Cattle, meat ....................
Cattle, meat byproducts
Goat, fat ..........................
Goat, meat ......................
Goat, meat byproducts ...
Horse, fat ........................
Horse, meat ....................
Horse, meat byproducts
Milk .................................
Sheep, fat .......................
Sheep, meat ...................
Sheep, meat byproducts
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.02
0.02
0.02
(b) Section 18 emergency exemptions.
[Reserved]
(c) Tolerances with regional
registrations. [Resereved]
(d) Indirect or inadvertant residues.
[Reserved]
[FR Doc. E8–15521 Filed 7–8–08; 8:45 am]
BILLING CODE 6560–50–S
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
9.0
[EPA–HQ–OPP–2007–0893; FRL–8370–9]
2.5
Almond, hulls ..................
Brassica, head and stem,
subgroup 5A ................
Brassica, leafy, subgroup
5B ................................
Citrus, oil .........................
Fruit, citrus, group 10 .....
Fruit, pome, group 11 .....
Fruit, stone, group 12 .....
Grape, raisin ...................
Hop, dried cones ............
Nut, tree, group 14 .........
Onion, bulb, subgroup
3A-07 ...........................
VerDate Aug<31>2005
9.0
(2) Tolerances are also established for
the combined residues of spirotetramat
(cis-3-(2,5-dimethlyphenyl)-8-methoxy2-oxo-1-azaspiro [4.5] dec-3-en-4-ylethyl carbonate) and its metabolite BYI
08330-enol (cis-3-(2,5-dimethylphenyl)4-hydroxy-8-methoxy-1-azaspiro 4.5
dec-3-en-2-one), calculated as
spirotetramat equivalents, in or on the
following commodities:
Authority: 21 U.S.C. 321(q), 346a and 371.
I
Project Number 4 (IR-4) requested these
tolerances under the Federal Food,
1.6 Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective July
9, 2008. Objections and requests for
1.3 hearings must be received on or before
0.40 September 8, 2008, and must be filed in
accordance with the instructions
0.30 provided in 40 CFR part 178 (see also
Unit I.C. of the SUPPLEMENTARY
2.5 INFORMATION).
Parts per million
Sethoxydim; Pesticide Tolerances
Environmental Protection
8.0 Agency (EPA).
6.0
ACTION: Final rule.
0.60
AGENCY:
0.70
4.5
3.0
10.0
0.25
SUMMARY: This regulation establishes
tolerances for combined residues of
sethoxydim and its metabolites
containing the 2-cyclohexen-1-one
moiety, in or on various oilseed
0.3 commodities. Interregional Research
Jkt 214001
PO 00000
Frm 00044
Fmt 4700
Sfmt 4700
EPA has established a
docket for this action under docket
identification (ID) number EPA–HQ–
OPP–2007–0893. To access the
electronic docket, go to https://
www.regulations.gov, select ‘‘Advanced
Search,’’ then ‘‘Docket Search.’’ Insert
the docket ID number where indicated
and select the ‘‘Submit’’ button. Follow
the instructions on the regulations.gov
website to view the docket index or
access available documents. All
documents in the docket are listed in
the docket index available in
regulations.gov. Although listed in the
index, some information is not publicly
available, e.g., Confidential Business
Information (CBI) or other information
whose disclosure is restricted by statute.
Certain other material, such as
copyrighted material, is not placed on
the Internet and will be publicly
available only in hard copy form.
Publicly available docket materials are
available in the electronic docket at
https://www.regulations.gov, or, if only
available in hard copy, at the OPP
Regulatory Public Docket in Rm. S–
4400, One Potomac Yard (South Bldg.),
2777 S. Crystal Dr., Arlington, VA. The
Docket Facility is open from 8:30 a.m.
to 4 p.m., Monday through Friday,
excluding legal holidays. The Docket
Facility telephone number is (703) 305–
5805.
FOR FURTHER INFORMATION CONTACT:
Susan Stanton, Registration Division
(7505P), Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001; telephone number:
(703) 305–5218; e-mail address:
stanton.susan@epa.gov.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. Potentially
affected entities may include, but are
not limited to those engaged in the
following activities:
• Crop production (NAICS code 111).
E:\FR\FM\09JYR1.SGM
09JYR1
Federal Register / Vol. 73, No. 132 / Wednesday, July 9, 2008 / Rules and Regulations
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
This listing is not intended to be
exhaustive, but rather to provide a guide
for readers regarding entities likely to be
affected by this action. Other types of
entities not listed in this unit could also
be affected. The North American
Industrial Classification System
(NAICS) codes have been provided to
assist you and others in determining
whether this action might apply to
certain entities. If you have any
questions regarding the applicability of
this action to a particular entity, consult
the person listed under FOR FURTHER
INFORMATION CONTACT.
B. How Can I Access Electronic Copies
of this Document?
In addition to accessing an electronic
copy of this Federal Register document
through the electronic docket at https://
www.regulations.gov, you may access
this Federal Register document
electronically through the EPA Internet
under the ‘‘Federal Register’’ listings at
https://www.epa.gov/fedrgstr. You may
also access a frequently updated
electronic version of EPA’s tolerance
regulations at 40 CFR part 180 through
the Government Printing Office’s pilot
e-CFR site at https://www.gpoaccess.gov/
ecfr.
dwashington3 on PRODPC61 with RULES
C. Can I File an Objection or Hearing
Request?
Under section 408(g) of FFDCA, any
person may file an objection to any
aspect of this regulation and may also
request a hearing on those objections.
You must file your objection or request
a hearing on this regulation in
accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2007–0893 in the subject line on
the first page of your submission. All
requests must be in writing, and must be
mailed or delivered to the Hearing Clerk
as required by 40 CFR part 178 on or
before September 8, 2008.
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing that does not
contain any CBI for inclusion in the
public docket that is described in
ADDRESSES. Information not marked
confidential pursuant to 40 CFR part 2
may be disclosed publicly by EPA
without prior notice. Submit this copy,
identified by docket ID number EPA–
VerDate Aug<31>2005
15:16 Jul 08, 2008
Jkt 214001
HQ–OPP–2007–0893, by one of the
following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the on-line
instructions for submitting comments.
• Mail: Office of Pesticide Programs
(OPP) Regulatory Public Docket (7502P),
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001.
• Delivery: OPP Regulatory Public
Docket (7502P), Environmental
Protection Agency, Rm. S–4400, One
Potomac Yard (South Bldg.), 2777 S.
Crystal Dr., Arlington, VA. Deliveries
are only accepted during the Docket’s
normal hours of operation (8:30 a.m. to
4 p.m., Monday through Friday,
excluding legal holidays). Special
arrangements should be made for
deliveries of boxed information. The
Docket Facility telephone number is
(703) 305–5805.
II. Petition for Tolerance
In the Federal Register of September
28, 2007 (72 FR 55204) (FRL–8147–1),
EPA issued a notice pursuant to section
408(d)(3) of FFDCA, 21 U.S.C.
346a(d)(3), announcing the filing of a
pesticide petition (PP 7E7232) by
Interregional Research Project Number 4
(IR–4), 500 College Road East, Suite
201W, Princeton, NJ 08540. The petition
requested that 40 CFR 180.412 be
amended by establishing tolerances for
combined residues of the herbicide
sethoxydim, 2-[1-(ethoxyimino)butyl]-5[2-(ethylthio)propyl]-3-hydroxy-2cyclohexen-1-one, and its metabolites
containing the 2-cyclohexen-1-one
moiety (calculated as the herbicide), in
or on cuphea, seed at 35.0 parts per
million (ppm); echium, seed at 35.0
ppm; gold of pleasure, seed at 35.0 ppm;
gold of pleasure, meal at 40.0 ppm;
hare’s ear mustard, seed at 35.0 ppm;
lesquerella, seed at 35.0 ppm; lunaria,
seed at 35.0 ppm; meadowfoam, seed at
35.0 ppm; milkweed, seed at 35.0 ppm;
mustard, seed at 35.0 ppm; oil radish,
seed at 35.0 ppm; poppy, seed at 35.0
ppm; sesame, seed at 35.0 ppm; sweet
rocket, seed at 35.0 ppm; crambe, seed
at 35.0 ppm; and crambe, meal at 40.0
ppm. That notice referenced a summary
of the petition prepared by BASF, the
registrant, on behalf of IR–4, which is
available to the public in the docket,
https://www.regulations.gov. There were
no comments received in response to
the notice of filing.
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA
allows EPA to establish a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
PO 00000
Frm 00045
Fmt 4700
Sfmt 4700
39257
determines that the tolerance is ‘‘safe.’’
Section 408(b)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings, but does not include
occupational exposure. Section
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue....’’
Consistent with section 408(b)(2)(D)
of FFDCA, and the factors specified in
section 408(b)(2)(D) of FFDCA, EPA has
reviewed the available scientific data
and other relevant information in
support of this action. EPA has
sufficient data to assess the hazards of
and to make a determination on
aggregate exposure for the petitioned-for
tolerances for combined residues of
sethoxydim and its metabolites
containing the 2-cyclohexen-1-one
moiety on crambe, meal at 40.0 ppm;
crambe, seed at 35.0 ppm; cuphea, seed
at 35.0 ppm; echium, seed at 35.0 ppm;
gold of pleasure, meal at 40.0 ppm; gold
of pleasure, seed at 35.0 ppm; hare’s ear
mustard, seed at 35.0 ppm; lesquerella,
seed at 35.0 ppm; lunaria, seed at 35.0
ppm; meadowfoam, seed at 35.0 ppm;
milkweed, seed at 35.0 ppm; mustard,
seed at 35.0 ppm; oil radish, seed at 35.0
ppm; poppy, seed at 35.0 ppm; sesame,
seed at 35.0 ppm; and sweet rocket, seed
at 35.0 ppm. EPA’s assessment of
exposures and risks associated with
establishing these tolerances follows.
A. Toxicological Profile
EPA has evaluated the available
toxicity data and considered its validity,
completeness, and reliability as well as
the relationship of the results of the
studies to human risk. EPA has also
considered available information
concerning the variability of the
sensitivities of major identifiable
subgroups of consumers, including
infants and children.
The acute toxicity data indicate that
sethoxydim is minimally toxic via oral,
dermal and inhalation routes of
exposure. It is neither irritating to the
eye nor the skin. With repeated dosing,
the primary target organ for this
chemical is the liver. In the chronic
toxicity study in dogs, there were
significantly increased absolute and
E:\FR\FM\09JYR1.SGM
09JYR1
39258
Federal Register / Vol. 73, No. 132 / Wednesday, July 9, 2008 / Rules and Regulations
dwashington3 on PRODPC61 with RULES
relative liver weights accompanied by
supportive clinical chemistry and
histopathology. Dose-related clinical
chemistry abnormalities were observed
in both sexes and included increased
alkaline phosphatase and aspartate
aminotransferase (ALT) and decreased
albumin and cholesterol synthesis.
Dose-related histopathologic lesions
were found in the liver, spleen and bone
marrow. A mild hepatocellular
cytoplasmic alteration was found in
males at all doses and in females at the
mid and high doses. Adverse liver
effects were also observed via the oral
route in mice and via the inhalation
route in rats. There was no evidence of
carcinogenicity in studies in rats and
mice and no evidence of mutagencity,
immunotoxicity or endocrine disruption
in the toxicity database for sethoxydim.
In the prenatal developmental studies in
rats and rabbits and reproductive
toxicity study in rats, the primary effects
noted in the young were fetal skeletal
variations and decreases in body weight.
Although effects suggestive of
neurotoxicity were noted in adult and
young rats in the developmental and/or
reproductive toxicity studies, EPA has
concluded that sethoxydim is not a
neurotoxic chemical. The weight of
evidence EPA considered in making this
determination is discussed in more
detail in Unit III.D.3.ii.
Specific information on the studies
received and the nature of the toxic
effects caused by sethoxydim as well as
the no-observed-adverse-effect-level
(NOAEL) and the lowest-observedadverse-effect-level (LOAEL) from the
toxicity studies can be found in the final
rule published in the Federal Register
of September 29, 2003 (68 FR 55858)
(FRL–7238–6)(https://www.epa.gov/EPAPEST/2003/September/Day–29/
p24562.htm).
B. Toxicological Endpoints
For hazards that have a threshold
below which there is no appreciable
risk, a toxicological point of departure
(POD) is identified as the basis for
derivation of reference values for risk
assessment. The POD may be defined as
the NOAEL in the toxicology study
identified as appropriate for use in risk
assessment. However, if a NOAEL
cannot be determined, the LOAEL or a
Benchmark Dose (BMD) approach is
sometimes used for risk assessment.
Uncertainty/safety factors (UFs) are
used in conjunction with the POD to
take into account uncertainties inherent
in the extrapolation from laboratory
animal data to humans and in the
variations in sensitivity among members
of the human population as well as
other unknowns. Safety is assessed for
VerDate Aug<31>2005
15:16 Jul 08, 2008
Jkt 214001
acute and chronic dietary risks by
comparing aggregate food and water
exposure to the pesticide to the acute
population adjusted dose (aPAD) and
chronic population adjusted dose
(cPAD). The aPAD and cPAD are
calculated by dividing the POD by all
applicable UFs. Aggregate short-term,
intermediate-term, and chronic-term
risks are evaluated by comparing food,
water, and residential exposure to the
POD to ensure that the margin of
exposure (MOE) called for by the
product of all applicable UFs is not
exceeded. This latter value is referred to
as the Level of Concern (LOC).
For non-threshold risks, the Agency
assumes that any amount of exposure
will lead to some degree of risk. Thus,
the Agency estimates risk in terms of the
probability of an occurrence of the
adverse effect greater than that expected
in a lifetime. For more information on
the general principles EPA uses in risk
characterization and a complete
description of the risk assessment
process, see https://www.epa.gov/
pesticides/factsheets/riskassess.htm.
A summary of the toxicological
endpoints for sethoxydim used for
human risk assessment can be found at
https://www.regulations.gov in the
document Sethoxydim: Amended
human health risk assessment to
support uses on the Rapeseed Crop
Subgroup 20A at page 10 in docket ID
number EPA–HQ–OPP–2007–0893.
C. Exposure Assessment
1. Dietary exposure from food and
feed uses. In evaluating dietary
exposure to sethoxydim, EPA
considered exposure under the
petitioned-for tolerances as well as all
existing sethoxydim tolerances in 40
CFR 180.412. EPA assessed dietary
exposures from sethoxydim in food as
follows:
i. Acute exposure. Quantitative acute
dietary exposure and risk assessments
are performed for a food-use pesticide if
a toxicological study has indicated the
possibility of an effect of concern
occurring as a result of a 1–day or single
exposure.
In estimating acute dietary exposure,
EPA used food consumption
information from the United States
Department of Agriculture (USDA)
1994–1996 and 1998 Nationwide
Continuing Surveys of Food Intake by
Individuals (CSFII). As to residue levels
in food, EPA assumed that 100 percent
of all crops with existing or pending
tolerances are treated with sethoxydim
and contain tolerance-level residues.
ii. Chronic exposure. In conducting
the chronic dietary exposure assessment
EPA used the food consumption data
PO 00000
Frm 00046
Fmt 4700
Sfmt 4700
from the USDA 1994–1996 and 1998
CSFII. As to residue levels in food, EPA
assumed that 100 percent of all crops
with existing or pending tolerances are
treated with sethoxydim and contain
tolerance-level residues.
iii. Cancer. Based on the results of
carcinogenicity studies in rats and mice,
EPA classified sethoxydim as ‘‘not
likely to be carcinogenic to humans’’;
therefore, an exposure assessment for
evaluating cancer risk is not needed for
this chemical.
iv. Anticipated residue and percent
crop treated (PCT) information. EPA did
not use anticipated residue or PCT
information in the dietary assessment
for sethoxydim. Tolerance level residues
and 100 PCT were assumed for all food
commodities.
2. Dietary exposure from drinking
water. The Agency used screening level
water exposure models in the dietary
exposure analysis and risk assessment
for sethoxydim in drinking water. These
simulation models take into account
data on the physical, chemical, and fate/
transport characteristics of sethoxydim.
Further information regarding EPA
drinking water models used in pesticide
exposure assessment can be found at
https://www.epa.gov/oppefed1/models/
water/index.htm.
Based on the First Index Reservoir
Screening Tool (FIRST) and Screening
Concentration in Ground Water (SCIGROW) models, the estimated drinking
water concentrations (EDWCs) of
sethoxydim for acute exposures are
estimated to be 130 parts per billion
(ppb) for surface water and 1.5 ppb for
ground water; and for chronic exposures
for non-cancer assessments are
estimated to be 16 ppb for surface water
and 1.5 ppb for ground water.
Modeled estimates of drinking water
concentrations were directly entered
into the dietary exposure model. For
acute dietary risk assessment, the water
concentration value of 130 ppb was
used to assess the contribution to
drinking water. For chronic dietary risk
assessment, the water concentration of
value 16 ppb was used to assess the
contribution to drinking water.
3. From non-dietary exposure. The
term ‘‘residential exposure’’ is used in
this document to refer to nonoccupational, non-dietary exposure
(e.g., for lawn and garden pest control,
indoor pest control, termiticides, and
flea and tick control on pets).
Sethoxydim is currently registered for
the following uses that could result in
residential exposures: Ornamentals and
flowering plants, recreational areas, and
buildings/structures (outdoor). EPA
assessed residential handler and
E:\FR\FM\09JYR1.SGM
09JYR1
Federal Register / Vol. 73, No. 132 / Wednesday, July 9, 2008 / Rules and Regulations
dwashington3 on PRODPC61 with RULES
postapplication exposures using the
following assumptions:
Homeowners who apply sethoxydim
to ornamental gardens and turf may be
exposed for short-term durations via the
dermal and inhalation routes. Dermal
endpoints of concern were not
identified for sethoxydim; therefore,
dermal exposure and risk assessments
are not appropriate. Short-term
inhalation exposure was assessed for
residential handlers who mix, load and
apply liquid sethoxydim products using
low-pressure hand wands, backpack
sprayers and garden hose-end sprayers.
Sethoxydim can be used in areas,
such as home lawns, that may be
frequented by adults and children.
There is potential for dermal exposure
of adults and children as well as
incidental oral exposure of children
following application of sethoxydim to
such areas. Post-application inhalation
exposure of adults and children is
expected to be negligible. Since there
are no dermal endpoints of concern for
sethoxydim, only post-application
incidental oral exposure of children was
assessed. EPA assessed incidental oral
exposure of toddlers from hand-tomouth, object-to-mouth and incidental
soil ingestion activities using Standard
Operating Procedures for Residential
Exposure Assessments.
4. Cumulative effects from substances
with a common mechanism of toxicity.
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
EPA has not found sethoxydim to
share a common mechanism of toxicity
with any other substances, and
sethoxydim does not appear to produce
a toxic metabolite produced by other
substances. For the purposes of this
tolerance action, therefore, EPA has
assumed that sethoxydim does not have
a common mechanism of toxicity with
other substances. For information
regarding EPA’s efforts to determine
which chemicals have a common
mechanism of toxicity and to evaluate
the cumulative effects of such
chemicals, see EPA’s website at https://
www.epa.gov/pesticides/cumulative.
D. Safety Factor for Infants and
Children
1. In general. Section 408(b)(2)(c) of
FFDCA provides that EPA shall apply
an additional tenfold (10X) margin of
safety for infants and children in the
case of threshold effects to account for
VerDate Aug<31>2005
15:16 Jul 08, 2008
Jkt 214001
prenatal and postnatal toxicity and the
completeness of the database on toxicity
and exposure unless EPA determines
based on reliable data that a different
margin of safety will be safe for infants
and children. This additional margin of
safety is commonly referred to as the
FQPA safety factor (SF). In applying this
provision, EPA either retains the default
value of 10X, or uses a different
additional safety factor when reliable
data available to EPA support the choice
of a different factor.
2. Prenatal and postnatal sensitivity.
The prenatal and postnatal toxicity
database for sethoxydim includes rat
and rabbit developmental toxicity
studies and a 2–generation reproduction
toxicity study in rats. There was no
evidence of increased quantitative or
qualitative susceptibility of in utero
rabbit fetuses following exposure to
sethoxydim in the rabbit developmental
study; however, evidence of increased
susceptibility was noted in the rat
developmental and reproduction
toxicity studies as described below:
There was some evidence of
qualitative susceptibility in the rat
developmental study with the
occurrence of more severe effects in the
fetuses (delayed ossification and tail
abnormalities) than in the maternal
animals (transient clinical signs
including: Irregular gait and decreased
activity) at the same dose. The degree of
concern for increased susceptibility in
this study is low and there are no
residual uncertainties for the following
reasons: The effects in the pups were of
low incidence and only observed at a
high dose that is considered to be close
to a limit dose. In addition, these effects
were seen in the presence of clear
maternal toxicity and clear NOAELs and
LOAELs were established for both
maternal and developmental toxicities.
In the 2–generation reproduction
study in rats, pups showed decreases in
body weight (11 to 13%) during
lactation at the high dose. At the same
dose, adult female animals exhibited
body weight losses (8 to 10%) that are
considered too small to qualify as an
adverse effect. The determination that
body weight effects occurred in pups at
a dose that did not result in maternal
toxicity is technically an indication of
quantitative susceptibility. However, the
degree of concern for the body weight
changes in pups is low, since the weight
changes are considered minimal and the
differences observed in body weight
losses between the adult and young
animals are marginal. Characterization
of the body weight changes as an
adverse effect in the pups is considered
conservative (protective).
PO 00000
Frm 00047
Fmt 4700
Sfmt 4700
39259
3. Conclusion. EPA has determined
that reliable data show the safety of
infants and children would be
adequately protected if the FQPA SF
were reduced to 1X. That decision is
based on the following findings:
i. The toxicity database for
sethoxydim is complete.
ii. Sethoxydim is not considered to be
a neurotoxic chemical and there is no
need for a developmental neurotoxicity
study or additional UFs to account for
neurotoxicity. Clinical signs suggestive
of neurotoxicity (including irregular
gait, decreased activity, excessive
salivation, and anogenital staining) were
observed in adult rats in the
developmental toxicity study. Because
the clinical signs occurred shortly after
dosing, only occurred at very high
treatment doses (over one half the limit
dose) and were transitory, it is unlikely
that the signs observed are the result of
a primary systemic effect on the nervous
system but, rather, are reflective of the
general toxicity at a high dose. An
increased incidence of fetal skeletal
variations due to delayed ossification
was seen in young rats in the
developmental and reproductive
toxicity studies. In the rat prenatal
study, tail abnormalities (filamentous
tail or lack of a tail) were noted. These
abnormalities were observed at a very
low incidence and at high treatment
doses. In the 2–generation reproduction
study in rats, a tail anomaly (short,
thread-like tail, no anal opening,
hindlimbs curved toward central
midline) was found in one pup in the
F2b generation (1/344 total pups; in 1/
4 litters). Tail abnormalities are
sometimes thought to relate to central
nervous system (CNS) malformations;
however, in this case, these tail
abnormalities are not likely to be the
result of a primary neural tube effect. In
the rat prenatal study, there is no
description of any effect on neural tubederived structures. No other effects
suggestive of neurotoxicity were seen in
toxicology studies conducted with
sethoxydim. Furthermore,
cyclohexones, the class of compounds
that includes sethoxydim, are not
known to cause neurotoxicity or
developmental malformations of the
nervous system. Based on the weight of
the evidence, EPA concluded that
sethoxydim is not neurotoxic.
iii. There is no evidence that
sethoxydim results in increased
susceptibility in in utero rabbits in the
prenatal developmental study. Although
there is qualitative evidence of
increased susceptibility in the prenatal
developmental study in rats and
equivocal evidence of quantitative
susceptibility in the 2–generation
E:\FR\FM\09JYR1.SGM
09JYR1
39260
Federal Register / Vol. 73, No. 132 / Wednesday, July 9, 2008 / Rules and Regulations
dwashington3 on PRODPC61 with RULES
reproduction study in rats, the degree of
concern is low, and the Agency did not
identify any residual uncertainties after
establishing toxicity endpoints and
traditional UFs to be used in the risk
assessment of sethoxydim.
iv. There are no residual uncertainties
identified in the exposure databases.
The dietary food exposure assessments
were performed assuming 100 PCT and
tolerance-level residues. EPA made
conservative (protective) assumptions in
the ground and surface water modeling
used to assess exposure to sethoxydim
in drinking water. EPA used similarly
conservative assumptions to assess
postapplication exposure of children as
well as incidental oral exposure of
toddlers. These assessments will not
underestimate the exposure and risks
posed by sethoxydim.
E. Aggregate Risks and Determination of
Safety
EPA determines whether acute and
chronic pesticide exposures are safe by
comparing aggregate exposure estimates
to the aPAD and cPAD. The aPAD and
cPAD represent the highest safe
exposures, taking into account all
appropriate SFs. EPA calculates the
aPAD and cPAD by dividing the POD by
all applicable UFs. For linear cancer
risks, EPA calculates the probability of
additional cancer cases given the
estimated aggregate exposure. Shortterm, intermediate-term, and chronicterm risks are evaluated by comparing
the estimated aggregate food, water, and
residential exposure to the POD to
ensure that the MOE called for by the
product of all applicable UFs is not
exceeded.
1. Acute risk. An acute aggregate risk
assessment takes into account exposure
estimates from acute dietary
consumption of food and drinking
water. Using the exposure assumptions
discussed in this unit for acute
exposure, the acute dietary exposure
from food and water to sethoxydim will
occupy 17% of the aPAD for children,
1 to 2 years old, the population group
receiving the greatest exposure.
2. Chronic risk. Using the exposure
assumptions described in this unit for
chronic exposure, EPA has concluded
that chronic exposure to sethoxydim
from food and water will utilize 94% of
the cPAD for children, 1 to 2 years old,
the population group receiving the
greatest exposure. Based on the
explanation in Unit III.C.3., regarding
residential use patterns, chronic
residential exposure to residues of
sethoxydim is not expected.
3. Short-term risk. Short-term
aggregate exposure takes into account
short-term residential exposure plus
VerDate Aug<31>2005
15:16 Jul 08, 2008
Jkt 214001
chronic exposure to food and water
(considered to be a background
exposure level). Sethoxydim is currently
registered for uses that could result in
short-term residential exposure and the
Agency has determined that it is
appropriate to aggregate chronic
exposure through food and water with
short-term residential exposures to
sethoxydim, except residential
inhalation exposures. It is not
appropriate to aggregate dietary (i.e.,
oral) exposures and inhalation
exposures because the toxic effects
identified for the oral and inhalation
exposure pathways differ.
Using the exposure assumptions
described in this unit for short-term
exposures, EPA has concluded the
combined short-term food, water, and
residential exposures aggregated result
in an aggregate MOE of 1,300 for
children 1 to 2 years old (toddlers). The
aggregate MOE for children includes
food, drinking water and postapplication incidental oral exposures
from entering turf areas previously
treated with sethoxydim. Adult
residential handler MOEs, based on
inhalation exposure of adults who mix,
load and apply liquid sethoxydim
products using low-pressure hand
wands, backpack sprayers or garden
hose-end sprayers, range from 1.4 x 106
to 1.6 x 106, with hose-end sprayers
resulting in the lowest MOE. As noted
in the previous paragraph, it is not
appropriate to aggregate chronic
exposure from food and water with
inhalation exposures. Post-application
inhalation exposure of adults and
children is expected to be negligible.
4. Intermediate-term risk.
Intermediate-term aggregate exposure
takes into account intermediate-term
residential exposure plus chronic
exposure to food and water (considered
to be a background exposure level).
Sethoxydim is not registered for any use
patterns that would result in
intermediate-term residential exposure.
Therefore, the intermediate-term
aggregate risk is the sum of the risk from
exposure to sethoxydim through food
and water, which has already been
addressed, and will not be greater than
the chronic aggregate risk.
5. Aggregate cancer risk for U.S.
population. EPA has classified
sethoxydim into the category ‘‘Not
Likely to be Carcinogenic to Humans.’’
Sethoxydim is not expected to pose a
cancer risk.
6. Determination of safety. Based on
these risk assessments, EPA concludes
that there is a reasonable certainty that
no harm will result to the general
population, or to infants and children
PO 00000
Frm 00048
Fmt 4700
Sfmt 4700
from aggregate exposure to sethoxydim
residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology
(gas chromatography with flame
photometric detection in the sulfur
mode; BASF Wyandotte Corporation’s
Method No. 30; 3/15/82; MRID
44864501; Method I, Pesticide
Analytical Methods Vol. II) is available
to enforce these oilseed tolerances.
B. International Residue Limits
There are no CODEX, Canadian or
Mexican maximum residue limits
(MRLs) established on the commodities
associated with this petition.
V. Conclusion
Therefore, tolerances are established
for combined residues of sethoxydim, 2[1-(ethoxyimino)butyl]-5-[2(ethylthio)propyl]-3-hydroxy-2cyclohexen-1-one, and its metabolites
containing the 2-cyclohexen-1-one
moiety, in or on crambe, meal at 40.0
ppm; crambe, seed at 35.0 ppm; cuphea,
seed at 35.0 ppm; echium, seed at 35.0
ppm; gold of pleasure, meal at 40.0
ppm; gold of pleasure, seed at 35.0 ppm;
hare’s ear mustard, seed at 35.0 ppm;
lesquerella, seed at 35.0 ppm; lunaria,
seed at 35.0 ppm; meadowfoam, seed at
35.0 ppm; milkweed, seed at 35.0 ppm;
mustard, seed at 35.0 ppm; oil radish,
seed at 35.0 ppm; poppy, seed at 35.0
ppm; sesame, seed at 35.0 ppm; and
sweet rocket, seed at 35.0 ppm.
VI. Statutory and Executive Order
Reviews
This final rule establishes tolerances
under section 408(d) of FFDCA in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled Regulatory
Planning and Review (58 FR 51735,
October 4, 1993). Because this final rule
has been exempted from review under
Executive Order 12866, this final rule is
not subject to Executive Order 13211,
Actions Concerning Regulations That
Significantly Affect Energy Supply,
Distribution, or Use (66 FR 28355, May
22, 2001) or Executive Order 13045,
entitled Protection of Children from
Environmental Health Risks and Safety
Risks (62 FR 19885, April 23, 1997).
This final rule does not contain any
information collections subject to OMB
approval under the Paperwork
Reduction Act (PRA), 44 U.S.C. 3501 et
seq., nor does it require any special
considerations under Executive Order
12898, entitled Federal Actions to
E:\FR\FM\09JYR1.SGM
09JYR1
Federal Register / Vol. 73, No. 132 / Wednesday, July 9, 2008 / Rules and Regulations
Address Environmental Justice in
Minority Populations and Low-Income
Populations (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under section 408(d) of FFDCA, such as
the tolerance in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.) do not apply.
This final rule directly regulates
growers, food processors, food handlers,
and food retailers, not States or tribes,
nor does this action alter the
relationships or distribution of power
and responsibilities established by
Congress in the preemption provisions
of section 408(n)(4) of FFDCA. As such,
the Agency has determined that this
action will not have a substantial direct
effect on States or tribal governments,
on the relationship between the national
government and the States or tribal
governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
tribes. Thus, the Agency has determined
that Executive Order 13132, entitled
Federalism (64 FR 43255, August 10,
1999) and Executive Order 13175,
entitled Consultation and Coordination
with Indian Tribal Governments (65 FR
67249, November 9, 2000) do not apply
to this final rule. In addition, this final
rule does not impose any enforceable
duty or contain any unfunded mandate
as described under Title II of the
Unfunded Mandates Reform Act of 1995
(UMRA) (Public Law 104–4).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act of 1995
(NTTAA), Public Law 104–113, section
12(d) (15 U.S.C. 272 note).
dwashington3 on PRODPC61 with RULES
VII. Congressional Review Act
The Congressional Review Act, 5
U.S.C. 801 et seq., generally provides
that before a rule may take effect, the
agency promulgating the rule must
submit a rule report to each House of
the Congress and to the Comptroller
General of the United States. EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of this final rule in the
Federal Register. This final rule is not
a ‘‘major rule’’ as defined by 5 U.S.C.
804(2).
VerDate Aug<31>2005
15:16 Jul 08, 2008
Jkt 214001
39261
List of Subjects in 40 CFR Part 180
*
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
[FR Doc. E8–15519 Filed 7–8–08; 8:45 am]
*
*
*
*
BILLING CODE 6560–50–S
ENVIRONMENTAL PROTECTION
AGENCY
Dated: June 30, 2008.
Lois Rossi,
Director, Registration Division, Office of
Pesticide Programs.
40 CFR Part 180
[EPA–HQ–OPP–2007–0096; FRL–8372–6]
I
Therefore, 40 CFR chapter I is
amended as follows:
Gamma-cyhalothrin; Pesticide
Tolerances
PART 180—[AMENDED]
AGENCY:
Environmental Protection
Agency (EPA).
ACTION: Final rule.
1. The authority citation for part 180
continues to read as follows:
I
SUMMARY: This regulation establishes
tolerances for residues of GammaI 2. Section 180.412 is amended by
cyhalothrin in or on all food
alphabetically adding the following
commodities (other than those already
commodities to the table in paragraph
covered by a higher tolerance as a result
(a) to read as follows:
of use on growing crops) in foodhandling establishments where food
§ 180.412 Sethoxydim; tolerances for
products are held, processed or
residues.
prepared, pistachio and okra. Pytech
(a) * * *
Chemicals GmbH and Interregional
Research Project No. 4 (IR-4) requested
Commodity
Parts per million
this tolerance under the Federal Food,
*
*
*
*
* Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective July
Crambe, meal .................
40.0 9, 2008. Objections and requests for
Crambe, seed .................
35.0 hearings must be received on or before
*
*
*
*
*
September 8, 2008, and must be filed in
Cuphea, seed .................
35.0 accordance with the instructions
*
*
*
*
* provided in 40 CFR part 178 (see also
Unit I.C. of the SUPPLEMENTARY
Echium, seed ..................
35.0 INFORMATION).
Authority: 21 U.S.C. 321(q), 346a and 371.
*
*
*
*
*
Gold of pleasure, meal ...
Gold of pleasure, seed ...
*
*
*
*
40.0
35.0
*
Hare’s ear mustard, seed
*
*
*
*
35.0
*
Lesquerella, seed ...........
*
*
*
*
35.0
*
*
35.0
35.0
*
Milkweed, seed ...............
Mustard, seed .................
*
*
*
*
35.0
35.0
*
Oil radish, seed ..............
*
*
*
*
35.0
*
Poppy, seed ....................
*
*
*
*
35.0
*
Sesame, seed .................
*
*
*
*
35.0
*
Sweet rocket, seed .........
*
*
*
*
35.0
*
Lunaria, seed ..................
Meadowfoam, seed ........
*
*
*
PO 00000
Frm 00049
Fmt 4700
Sfmt 4700
EPA has established a
docket for this action under docket
identification (ID) number EPA–HQ–
OPP–2007–0096. To access the
electronic docket, go to https://
www.regulations.gov, select ‘‘Advanced
Search,’’ then ‘‘Docket Search.’’ Insert
the docket ID number where indicated
and select the ‘‘Submit’’ button. Follow
the instructions on the regulations.gov
website to view the docket index or
access available documents. All
documents in the docket are listed in
the docket index available in
regulations.gov. Although listed in the
index, some information is not publicly
available, e.g., Confidential Business
Information (CBI) or other information
whose disclosure is restricted by statute.
Certain other material, such as
copyrighted material, is not placed on
the Internet and will be publicly
available only in hard copy form.
Publicly available docket materials are
available in the electronic docket at
https://www.regulations.gov, or, if only
available in hard copy, at the OPP
Regulatory Public Docket in Rm. S–
4400, One Potomac Yard (South Bldg.),
ADDRESSES:
E:\FR\FM\09JYR1.SGM
09JYR1
Agencies
[Federal Register Volume 73, Number 132 (Wednesday, July 9, 2008)]
[Rules and Regulations]
[Pages 39256-39261]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-15519]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2007-0893; FRL-8370-9]
Sethoxydim; Pesticide Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes tolerances for combined residues
of sethoxydim and its metabolites containing the 2-cyclohexen-1-one
moiety, in or on various oilseed commodities. Interregional Research
Project Number 4 (IR-4) requested these tolerances under the Federal
Food, Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective July 9, 2008. Objections and
requests for hearings must be received on or before September 8, 2008,
and must be filed in accordance with the instructions provided in 40
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: EPA has established a docket for this action under docket
identification (ID) number EPA-HQ-OPP-2007-0893. To access the
electronic docket, go to https://www.regulations.gov, select ``Advanced
Search,'' then ``Docket Search.'' Insert the docket ID number where
indicated and select the ``Submit'' button. Follow the instructions on
the regulations.gov website to view the docket index or access
available documents. All documents in the docket are listed in the
docket index available in regulations.gov. Although listed in the
index, some information is not publicly available, e.g., Confidential
Business Information (CBI) or other information whose disclosure is
restricted by statute. Certain other material, such as copyrighted
material, is not placed on the Internet and will be publicly available
only in hard copy form. Publicly available docket materials are
available in the electronic docket at https://www.regulations.gov, or,
if only available in hard copy, at the OPP Regulatory Public Docket in
Rm. S-4400, One Potomac Yard (South Bldg.), 2777 S. Crystal Dr.,
Arlington, VA. The Docket Facility is open from 8:30 a.m. to 4 p.m.,
Monday through Friday, excluding legal holidays. The Docket Facility
telephone number is (703) 305-5805.
FOR FURTHER INFORMATION CONTACT: Susan Stanton, Registration Division
(7505P), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone
number: (703) 305-5218; e-mail address: stanton.susan@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
Potentially affected entities may include, but are not limited to those
engaged in the following activities:
Crop production (NAICS code 111).
[[Page 39257]]
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
This listing is not intended to be exhaustive, but rather to
provide a guide for readers regarding entities likely to be affected by
this action. Other types of entities not listed in this unit could also
be affected. The North American Industrial Classification System
(NAICS) codes have been provided to assist you and others in
determining whether this action might apply to certain entities. If you
have any questions regarding the applicability of this action to a
particular entity, consult the person listed under FOR FURTHER
INFORMATION CONTACT.
B. How Can I Access Electronic Copies of this Document?
In addition to accessing an electronic copy of this Federal
Register document through the electronic docket at https://
www.regulations.gov, you may access this Federal Register document
electronically through the EPA Internet under the ``Federal Register''
listings at https://www.epa.gov/fedrgstr. You may also access a
frequently updated electronic version of EPA's tolerance regulations at
40 CFR part 180 through the Government Printing Office's pilot e-CFR
site at https://www.gpoaccess.gov/ecfr.
C. Can I File an Objection or Hearing Request?
Under section 408(g) of FFDCA, any person may file an objection to
any aspect of this regulation and may also request a hearing on those
objections. You must file your objection or request a hearing on this
regulation in accordance with the instructions provided in 40 CFR part
178. To ensure proper receipt by EPA, you must identify docket ID
number EPA-HQ-OPP-2007-0893 in the subject line on the first page of
your submission. All requests must be in writing, and must be mailed or
delivered to the Hearing Clerk as required by 40 CFR part 178 on or
before September 8, 2008.
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing that does not contain any CBI for inclusion in the public
docket that is described in ADDRESSES. Information not marked
confidential pursuant to 40 CFR part 2 may be disclosed publicly by EPA
without prior notice. Submit this copy, identified by docket ID number
EPA-HQ-OPP-2007-0893, by one of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the on-line instructions for submitting comments.
Mail: Office of Pesticide Programs (OPP) Regulatory Public
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460-0001.
Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only
accepted during the Docket's normal hours of operation (8:30 a.m. to 4
p.m., Monday through Friday, excluding legal holidays). Special
arrangements should be made for deliveries of boxed information. The
Docket Facility telephone number is (703) 305-5805.
II. Petition for Tolerance
In the Federal Register of September 28, 2007 (72 FR 55204) (FRL-
8147-1), EPA issued a notice pursuant to section 408(d)(3) of FFDCA, 21
U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP
7E7232) by Interregional Research Project Number 4 (IR-4), 500 College
Road East, Suite 201W, Princeton, NJ 08540. The petition requested that
40 CFR 180.412 be amended by establishing tolerances for combined
residues of the herbicide sethoxydim, 2-[1-(ethoxyimino)butyl]-5-[2-
(ethylthio)propyl]-3-hydroxy-2-cyclohexen-1-one, and its metabolites
containing the 2-cyclohexen-1-one moiety (calculated as the herbicide),
in or on cuphea, seed at 35.0 parts per million (ppm); echium, seed at
35.0 ppm; gold of pleasure, seed at 35.0 ppm; gold of pleasure, meal at
40.0 ppm; hare's ear mustard, seed at 35.0 ppm; lesquerella, seed at
35.0 ppm; lunaria, seed at 35.0 ppm; meadowfoam, seed at 35.0 ppm;
milkweed, seed at 35.0 ppm; mustard, seed at 35.0 ppm; oil radish, seed
at 35.0 ppm; poppy, seed at 35.0 ppm; sesame, seed at 35.0 ppm; sweet
rocket, seed at 35.0 ppm; crambe, seed at 35.0 ppm; and crambe, meal at
40.0 ppm. That notice referenced a summary of the petition prepared by
BASF, the registrant, on behalf of IR-4, which is available to the
public in the docket, https://www.regulations.gov. There were no
comments received in response to the notice of filing.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings, but does not include occupational exposure.
Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical
residue....''
Consistent with section 408(b)(2)(D) of FFDCA, and the factors
specified in section 408(b)(2)(D) of FFDCA, EPA has reviewed the
available scientific data and other relevant information in support of
this action. EPA has sufficient data to assess the hazards of and to
make a determination on aggregate exposure for the petitioned-for
tolerances for combined residues of sethoxydim and its metabolites
containing the 2-cyclohexen-1-one moiety on crambe, meal at 40.0 ppm;
crambe, seed at 35.0 ppm; cuphea, seed at 35.0 ppm; echium, seed at
35.0 ppm; gold of pleasure, meal at 40.0 ppm; gold of pleasure, seed at
35.0 ppm; hare's ear mustard, seed at 35.0 ppm; lesquerella, seed at
35.0 ppm; lunaria, seed at 35.0 ppm; meadowfoam, seed at 35.0 ppm;
milkweed, seed at 35.0 ppm; mustard, seed at 35.0 ppm; oil radish, seed
at 35.0 ppm; poppy, seed at 35.0 ppm; sesame, seed at 35.0 ppm; and
sweet rocket, seed at 35.0 ppm. EPA's assessment of exposures and risks
associated with establishing these tolerances follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children.
The acute toxicity data indicate that sethoxydim is minimally toxic
via oral, dermal and inhalation routes of exposure. It is neither
irritating to the eye nor the skin. With repeated dosing, the primary
target organ for this chemical is the liver. In the chronic toxicity
study in dogs, there were significantly increased absolute and
[[Page 39258]]
relative liver weights accompanied by supportive clinical chemistry and
histopathology. Dose-related clinical chemistry abnormalities were
observed in both sexes and included increased alkaline phosphatase and
aspartate aminotransferase (ALT) and decreased albumin and cholesterol
synthesis. Dose-related histopathologic lesions were found in the
liver, spleen and bone marrow. A mild hepatocellular cytoplasmic
alteration was found in males at all doses and in females at the mid
and high doses. Adverse liver effects were also observed via the oral
route in mice and via the inhalation route in rats. There was no
evidence of carcinogenicity in studies in rats and mice and no evidence
of mutagencity, immunotoxicity or endocrine disruption in the toxicity
database for sethoxydim. In the prenatal developmental studies in rats
and rabbits and reproductive toxicity study in rats, the primary
effects noted in the young were fetal skeletal variations and decreases
in body weight. Although effects suggestive of neurotoxicity were noted
in adult and young rats in the developmental and/or reproductive
toxicity studies, EPA has concluded that sethoxydim is not a neurotoxic
chemical. The weight of evidence EPA considered in making this
determination is discussed in more detail in Unit III.D.3.ii.
Specific information on the studies received and the nature of the
toxic effects caused by sethoxydim as well as the no-observed-adverse-
effect-level (NOAEL) and the lowest-observed-adverse-effect-level
(LOAEL) from the toxicity studies can be found in the final rule
published in the Federal Register of September 29, 2003 (68 FR 55858)
(FRL-7238-6)(https://www.epa.gov/EPA-PEST/2003/September/Day-29/
p24562.htm).
B. Toxicological Endpoints
For hazards that have a threshold below which there is no
appreciable risk, a toxicological point of departure (POD) is
identified as the basis for derivation of reference values for risk
assessment. The POD may be defined as the NOAEL in the toxicology study
identified as appropriate for use in risk assessment. However, if a
NOAEL cannot be determined, the LOAEL or a Benchmark Dose (BMD)
approach is sometimes used for risk assessment. Uncertainty/safety
factors (UFs) are used in conjunction with the POD to take into account
uncertainties inherent in the extrapolation from laboratory animal data
to humans and in the variations in sensitivity among members of the
human population as well as other unknowns. Safety is assessed for
acute and chronic dietary risks by comparing aggregate food and water
exposure to the pesticide to the acute population adjusted dose (aPAD)
and chronic population adjusted dose (cPAD). The aPAD and cPAD are
calculated by dividing the POD by all applicable UFs. Aggregate short-
term, intermediate-term, and chronic-term risks are evaluated by
comparing food, water, and residential exposure to the POD to ensure
that the margin of exposure (MOE) called for by the product of all
applicable UFs is not exceeded. This latter value is referred to as the
Level of Concern (LOC).
For non-threshold risks, the Agency assumes that any amount of
exposure will lead to some degree of risk. Thus, the Agency estimates
risk in terms of the probability of an occurrence of the adverse effect
greater than that expected in a lifetime. For more information on the
general principles EPA uses in risk characterization and a complete
description of the risk assessment process, see https://www.epa.gov/
pesticides/factsheets/riskassess.htm.
A summary of the toxicological endpoints for sethoxydim used for
human risk assessment can be found at https://www.regulations.gov in the
document Sethoxydim: Amended human health risk assessment to support
uses on the Rapeseed Crop Subgroup 20A at page 10 in docket ID number
EPA-HQ-OPP-2007-0893.
C. Exposure Assessment
1. Dietary exposure from food and feed uses. In evaluating dietary
exposure to sethoxydim, EPA considered exposure under the petitioned-
for tolerances as well as all existing sethoxydim tolerances in 40 CFR
180.412. EPA assessed dietary exposures from sethoxydim in food as
follows:
i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a 1-day or single exposure.
In estimating acute dietary exposure, EPA used food consumption
information from the United States Department of Agriculture (USDA)
1994-1996 and 1998 Nationwide Continuing Surveys of Food Intake by
Individuals (CSFII). As to residue levels in food, EPA assumed that 100
percent of all crops with existing or pending tolerances are treated
with sethoxydim and contain tolerance-level residues.
ii. Chronic exposure. In conducting the chronic dietary exposure
assessment EPA used the food consumption data from the USDA 1994-1996
and 1998 CSFII. As to residue levels in food, EPA assumed that 100
percent of all crops with existing or pending tolerances are treated
with sethoxydim and contain tolerance-level residues.
iii. Cancer. Based on the results of carcinogenicity studies in
rats and mice, EPA classified sethoxydim as ``not likely to be
carcinogenic to humans''; therefore, an exposure assessment for
evaluating cancer risk is not needed for this chemical.
iv. Anticipated residue and percent crop treated (PCT) information.
EPA did not use anticipated residue or PCT information in the dietary
assessment for sethoxydim. Tolerance level residues and 100 PCT were
assumed for all food commodities.
2. Dietary exposure from drinking water. The Agency used screening
level water exposure models in the dietary exposure analysis and risk
assessment for sethoxydim in drinking water. These simulation models
take into account data on the physical, chemical, and fate/transport
characteristics of sethoxydim. Further information regarding EPA
drinking water models used in pesticide exposure assessment can be
found at https://www.epa.gov/oppefed1/models/water/index.htm.
Based on the First Index Reservoir Screening Tool (FIRST) and
Screening Concentration in Ground Water (SCI-GROW) models, the
estimated drinking water concentrations (EDWCs) of sethoxydim for acute
exposures are estimated to be 130 parts per billion (ppb) for surface
water and 1.5 ppb for ground water; and for chronic exposures for non-
cancer assessments are estimated to be 16 ppb for surface water and 1.5
ppb for ground water.
Modeled estimates of drinking water concentrations were directly
entered into the dietary exposure model. For acute dietary risk
assessment, the water concentration value of 130 ppb was used to assess
the contribution to drinking water. For chronic dietary risk
assessment, the water concentration of value 16 ppb was used to assess
the contribution to drinking water.
3. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., for lawn and garden pest control, indoor pest control,
termiticides, and flea and tick control on pets).
Sethoxydim is currently registered for the following uses that
could result in residential exposures: Ornamentals and flowering
plants, recreational areas, and buildings/structures (outdoor). EPA
assessed residential handler and
[[Page 39259]]
postapplication exposures using the following assumptions:
Homeowners who apply sethoxydim to ornamental gardens and turf may
be exposed for short-term durations via the dermal and inhalation
routes. Dermal endpoints of concern were not identified for sethoxydim;
therefore, dermal exposure and risk assessments are not appropriate.
Short-term inhalation exposure was assessed for residential handlers
who mix, load and apply liquid sethoxydim products using low-pressure
hand wands, backpack sprayers and garden hose-end sprayers.
Sethoxydim can be used in areas, such as home lawns, that may be
frequented by adults and children. There is potential for dermal
exposure of adults and children as well as incidental oral exposure of
children following application of sethoxydim to such areas. Post-
application inhalation exposure of adults and children is expected to
be negligible. Since there are no dermal endpoints of concern for
sethoxydim, only post-application incidental oral exposure of children
was assessed. EPA assessed incidental oral exposure of toddlers from
hand-to-mouth, object-to-mouth and incidental soil ingestion activities
using Standard Operating Procedures for Residential Exposure
Assessments.
4. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
EPA has not found sethoxydim to share a common mechanism of
toxicity with any other substances, and sethoxydim does not appear to
produce a toxic metabolite produced by other substances. For the
purposes of this tolerance action, therefore, EPA has assumed that
sethoxydim does not have a common mechanism of toxicity with other
substances. For information regarding EPA's efforts to determine which
chemicals have a common mechanism of toxicity and to evaluate the
cumulative effects of such chemicals, see EPA's website at https://
www.epa.gov/pesticides/cumulative.
D. Safety Factor for Infants and Children
1. In general. Section 408(b)(2)(c) of FFDCA provides that EPA
shall apply an additional tenfold (10X) margin of safety for infants
and children in the case of threshold effects to account for prenatal
and postnatal toxicity and the completeness of the database on toxicity
and exposure unless EPA determines based on reliable data that a
different margin of safety will be safe for infants and children. This
additional margin of safety is commonly referred to as the FQPA safety
factor (SF). In applying this provision, EPA either retains the default
value of 10X, or uses a different additional safety factor when
reliable data available to EPA support the choice of a different
factor.
2. Prenatal and postnatal sensitivity. The prenatal and postnatal
toxicity database for sethoxydim includes rat and rabbit developmental
toxicity studies and a 2-generation reproduction toxicity study in
rats. There was no evidence of increased quantitative or qualitative
susceptibility of in utero rabbit fetuses following exposure to
sethoxydim in the rabbit developmental study; however, evidence of
increased susceptibility was noted in the rat developmental and
reproduction toxicity studies as described below:
There was some evidence of qualitative susceptibility in the rat
developmental study with the occurrence of more severe effects in the
fetuses (delayed ossification and tail abnormalities) than in the
maternal animals (transient clinical signs including: Irregular gait
and decreased activity) at the same dose. The degree of concern for
increased susceptibility in this study is low and there are no residual
uncertainties for the following reasons: The effects in the pups were
of low incidence and only observed at a high dose that is considered to
be close to a limit dose. In addition, these effects were seen in the
presence of clear maternal toxicity and clear NOAELs and LOAELs were
established for both maternal and developmental toxicities.
In the 2-generation reproduction study in rats, pups showed
decreases in body weight (11 to 13%) during lactation at the high dose.
At the same dose, adult female animals exhibited body weight losses (8
to 10%) that are considered too small to qualify as an adverse effect.
The determination that body weight effects occurred in pups at a dose
that did not result in maternal toxicity is technically an indication
of quantitative susceptibility. However, the degree of concern for the
body weight changes in pups is low, since the weight changes are
considered minimal and the differences observed in body weight losses
between the adult and young animals are marginal. Characterization of
the body weight changes as an adverse effect in the pups is considered
conservative (protective).
3. Conclusion. EPA has determined that reliable data show the
safety of infants and children would be adequately protected if the
FQPA SF were reduced to 1X. That decision is based on the following
findings:
i. The toxicity database for sethoxydim is complete.
ii. Sethoxydim is not considered to be a neurotoxic chemical and
there is no need for a developmental neurotoxicity study or additional
UFs to account for neurotoxicity. Clinical signs suggestive of
neurotoxicity (including irregular gait, decreased activity, excessive
salivation, and anogenital staining) were observed in adult rats in the
developmental toxicity study. Because the clinical signs occurred
shortly after dosing, only occurred at very high treatment doses (over
one half the limit dose) and were transitory, it is unlikely that the
signs observed are the result of a primary systemic effect on the
nervous system but, rather, are reflective of the general toxicity at a
high dose. An increased incidence of fetal skeletal variations due to
delayed ossification was seen in young rats in the developmental and
reproductive toxicity studies. In the rat prenatal study, tail
abnormalities (filamentous tail or lack of a tail) were noted. These
abnormalities were observed at a very low incidence and at high
treatment doses. In the 2-generation reproduction study in rats, a tail
anomaly (short, thread-like tail, no anal opening, hindlimbs curved
toward central midline) was found in one pup in the F2b generation (1/
344 total pups; in 1/4 litters). Tail abnormalities are sometimes
thought to relate to central nervous system (CNS) malformations;
however, in this case, these tail abnormalities are not likely to be
the result of a primary neural tube effect. In the rat prenatal study,
there is no description of any effect on neural tube-derived
structures. No other effects suggestive of neurotoxicity were seen in
toxicology studies conducted with sethoxydim. Furthermore,
cyclohexones, the class of compounds that includes sethoxydim, are not
known to cause neurotoxicity or developmental malformations of the
nervous system. Based on the weight of the evidence, EPA concluded that
sethoxydim is not neurotoxic.
iii. There is no evidence that sethoxydim results in increased
susceptibility in in utero rabbits in the prenatal developmental study.
Although there is qualitative evidence of increased susceptibility in
the prenatal developmental study in rats and equivocal evidence of
quantitative susceptibility in the 2-generation
[[Page 39260]]
reproduction study in rats, the degree of concern is low, and the
Agency did not identify any residual uncertainties after establishing
toxicity endpoints and traditional UFs to be used in the risk
assessment of sethoxydim.
iv. There are no residual uncertainties identified in the exposure
databases. The dietary food exposure assessments were performed
assuming 100 PCT and tolerance-level residues. EPA made conservative
(protective) assumptions in the ground and surface water modeling used
to assess exposure to sethoxydim in drinking water. EPA used similarly
conservative assumptions to assess postapplication exposure of children
as well as incidental oral exposure of toddlers. These assessments will
not underestimate the exposure and risks posed by sethoxydim.
E. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic pesticide exposures are
safe by comparing aggregate exposure estimates to the aPAD and cPAD.
The aPAD and cPAD represent the highest safe exposures, taking into
account all appropriate SFs. EPA calculates the aPAD and cPAD by
dividing the POD by all applicable UFs. For linear cancer risks, EPA
calculates the probability of additional cancer cases given the
estimated aggregate exposure. Short-term, intermediate-term, and
chronic-term risks are evaluated by comparing the estimated aggregate
food, water, and residential exposure to the POD to ensure that the MOE
called for by the product of all applicable UFs is not exceeded.
1. Acute risk. An acute aggregate risk assessment takes into
account exposure estimates from acute dietary consumption of food and
drinking water. Using the exposure assumptions discussed in this unit
for acute exposure, the acute dietary exposure from food and water to
sethoxydim will occupy 17% of the aPAD for children, 1 to 2 years old,
the population group receiving the greatest exposure.
2. Chronic risk. Using the exposure assumptions described in this
unit for chronic exposure, EPA has concluded that chronic exposure to
sethoxydim from food and water will utilize 94% of the cPAD for
children, 1 to 2 years old, the population group receiving the greatest
exposure. Based on the explanation in Unit III.C.3., regarding
residential use patterns, chronic residential exposure to residues of
sethoxydim is not expected.
3. Short-term risk. Short-term aggregate exposure takes into
account short-term residential exposure plus chronic exposure to food
and water (considered to be a background exposure level). Sethoxydim is
currently registered for uses that could result in short-term
residential exposure and the Agency has determined that it is
appropriate to aggregate chronic exposure through food and water with
short-term residential exposures to sethoxydim, except residential
inhalation exposures. It is not appropriate to aggregate dietary (i.e.,
oral) exposures and inhalation exposures because the toxic effects
identified for the oral and inhalation exposure pathways differ.
Using the exposure assumptions described in this unit for short-
term exposures, EPA has concluded the combined short-term food, water,
and residential exposures aggregated result in an aggregate MOE of
1,300 for children 1 to 2 years old (toddlers). The aggregate MOE for
children includes food, drinking water and post-application incidental
oral exposures from entering turf areas previously treated with
sethoxydim. Adult residential handler MOEs, based on inhalation
exposure of adults who mix, load and apply liquid sethoxydim products
using low-pressure hand wands, backpack sprayers or garden hose-end
sprayers, range from 1.4 x 10\6\ to 1.6 x 10\6\, with hose-end sprayers
resulting in the lowest MOE. As noted in the previous paragraph, it is
not appropriate to aggregate chronic exposure from food and water with
inhalation exposures. Post-application inhalation exposure of adults
and children is expected to be negligible.
4. Intermediate-term risk. Intermediate-term aggregate exposure
takes into account intermediate-term residential exposure plus chronic
exposure to food and water (considered to be a background exposure
level). Sethoxydim is not registered for any use patterns that would
result in intermediate-term residential exposure. Therefore, the
intermediate-term aggregate risk is the sum of the risk from exposure
to sethoxydim through food and water, which has already been addressed,
and will not be greater than the chronic aggregate risk.
5. Aggregate cancer risk for U.S. population. EPA has classified
sethoxydim into the category ``Not Likely to be Carcinogenic to
Humans.'' Sethoxydim is not expected to pose a cancer risk.
6. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population, or to infants and children from aggregate
exposure to sethoxydim residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology (gas chromatography with flame
photometric detection in the sulfur mode; BASF Wyandotte Corporation's
Method No. 30; 3/15/82; MRID 44864501; Method I, Pesticide Analytical
Methods Vol. II) is available to enforce these oilseed tolerances.
B. International Residue Limits
There are no CODEX, Canadian or Mexican maximum residue limits
(MRLs) established on the commodities associated with this petition.
V. Conclusion
Therefore, tolerances are established for combined residues of
sethoxydim, 2-[1-(ethoxyimino)butyl]-5-[2-(ethylthio)propyl]-3-hydroxy-
2-cyclohexen-1-one, and its metabolites containing the 2-cyclohexen-1-
one moiety, in or on crambe, meal at 40.0 ppm; crambe, seed at 35.0
ppm; cuphea, seed at 35.0 ppm; echium, seed at 35.0 ppm; gold of
pleasure, meal at 40.0 ppm; gold of pleasure, seed at 35.0 ppm; hare's
ear mustard, seed at 35.0 ppm; lesquerella, seed at 35.0 ppm; lunaria,
seed at 35.0 ppm; meadowfoam, seed at 35.0 ppm; milkweed, seed at 35.0
ppm; mustard, seed at 35.0 ppm; oil radish, seed at 35.0 ppm; poppy,
seed at 35.0 ppm; sesame, seed at 35.0 ppm; and sweet rocket, seed at
35.0 ppm.
VI. Statutory and Executive Order Reviews
This final rule establishes tolerances under section 408(d) of
FFDCA in response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled Regulatory Planning and
Review (58 FR 51735, October 4, 1993). Because this final rule has been
exempted from review under Executive Order 12866, this final rule is
not subject to Executive Order 13211, Actions Concerning Regulations
That Significantly Affect Energy Supply, Distribution, or Use (66 FR
28355, May 22, 2001) or Executive Order 13045, entitled Protection of
Children from Environmental Health Risks and Safety Risks (62 FR 19885,
April 23, 1997). This final rule does not contain any information
collections subject to OMB approval under the Paperwork Reduction Act
(PRA), 44 U.S.C. 3501 et seq., nor does it require any special
considerations under Executive Order 12898, entitled Federal Actions to
[[Page 39261]]
Address Environmental Justice in Minority Populations and Low-Income
Populations (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under section 408(d) of FFDCA, such as the tolerance in
this final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.) do not apply.
This final rule directly regulates growers, food processors, food
handlers, and food retailers, not States or tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of section 408(n)(4) of FFDCA. As such, the Agency has determined that
this action will not have a substantial direct effect on States or
tribal governments, on the relationship between the national government
and the States or tribal governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian tribes. Thus, the Agency has
determined that Executive Order 13132, entitled Federalism (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
Consultation and Coordination with Indian Tribal Governments (65 FR
67249, November 9, 2000) do not apply to this final rule. In addition,
this final rule does not impose any enforceable duty or contain any
unfunded mandate as described under Title II of the Unfunded Mandates
Reform Act of 1995 (UMRA) (Public Law 104-4).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act of 1995 (NTTAA), Public Law 104-113, section 12(d) (15 U.S.C. 272
note).
VII. Congressional Review Act
The Congressional Review Act, 5 U.S.C. 801 et seq., generally
provides that before a rule may take effect, the agency promulgating
the rule must submit a rule report to each House of the Congress and to
the Comptroller General of the United States. EPA will submit a report
containing this rule and other required information to the U.S. Senate,
the U.S. House of Representatives, and the Comptroller General of the
United States prior to publication of this final rule in the Federal
Register. This final rule is not a ``major rule'' as defined by 5
U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: June 30, 2008.
Lois Rossi,
Director, Registration Division, Office of Pesticide Programs.
0
Therefore, 40 CFR chapter I is amended as follows:
PART 180--[AMENDED]
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. Section 180.412 is amended by alphabetically adding the following
commodities to the table in paragraph (a) to read as follows:
Sec. 180.412 Sethoxydim; tolerances for residues.
(a) * * *
------------------------------------------------------------------------
Commodity Parts per million
------------------------------------------------------------------------
* * * * *
Crambe, meal......................................... 40.0
Crambe, seed......................................... 35.0
* * * * *
Cuphea, seed......................................... 35.0
* * * * *
Echium, seed......................................... 35.0
* * * * *
Gold of pleasure, meal............................... 40.0
Gold of pleasure, seed............................... 35.0
* * * * *
Hare's ear mustard, seed............................. 35.0
* * * * *
Lesquerella, seed.................................... 35.0
* * * * *
Lunaria, seed........................................ 35.0
Meadowfoam, seed..................................... 35.0
* * * * *
Milkweed, seed....................................... 35.0
Mustard, seed........................................ 35.0
* * * * *
Oil radish, seed..................................... 35.0
* * * * *
Poppy, seed.......................................... 35.0
* * * * *
Sesame, seed......................................... 35.0
* * * * *
Sweet rocket, seed................................... 35.0
* * * * *
------------------------------------------------------------------------
* * * * *
[FR Doc. E8-15519 Filed 7-8-08; 8:45 am]
BILLING CODE 6560-50-S